A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery

Multiple Sclerosis Clinical Trial

Official title:

A Multi-Center Longitudinal Biorepository Study to Provide Biospecimens & Clinical Data From Neurological Disease Patients To Approved Pre-Clinical And Clinical Investigators for Drug & Biomarker Studies

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01592552
• Other study ID #: SAN-ND-01
• Status: Completed
• Start date: November 2011
• Est. completion date: March 2015

Study information

• Verified date: November 2023
• Source: Sanguine Biosciences
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.

Description:

Blood samples are collected in the comfort and safety of your home by a certified medical professional. We have mobile phlebotomists located in major metropolitan areas around the nation for your convenience.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: March 2015
• Est. primary completion date: March 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Males and females >18 to 100 years old

• A diagnosis of neurological condition

• Proof of diagnosis can be provided

Control group: Healthy donors, males and females, 18 to 100 years of age

Exclusion Criteria

• Receipt of blood products within 30 days of study enrollment

• Receipt of an investigational (unapproved) drug within 30 days of study enrollment

Related Conditions & MeSH terms

• Alzheimer Disease
• Alzheimer's Disease
• Amyotrophic Lateral Sclerosis
• Amyotrophic Lateral Sclerosis (ALS)
• Huntington Disease
• Huntington's Disease
• Motor Neuron Disease
• Multiple Sclerosis
• Parkinson Disease
• Parkinson's Disease
• Sclerosis

Locations

Country	Name	City	State
United States	Sanguine Biosciences	Sherman Oaks	California

Sponsors (1)

Lead Sponsor	Collaborator
Sanguine Biosciences

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Biospecimens & Clinical Data collection from patients with neurological diseases.	The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.	2 years